A novel combination therapy for effective treatment of cancer by designed anti-immunosuppressive nanoregulator and radiofrequency ablation.
- DOI
- 10.1016/j.biomaterials.2026.124561
- Published
- 2027 Feb
- Container
- Biomaterials
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biomaterials.2026.124561,
title = {A novel combination therapy for effective treatment of cancer by designed anti-immunosuppressive nanoregulator and radiofrequency ablation.},
author = {Fang S and Chen J and Zheng L and Guo X and Han M and Ding Y and Qin P and Hou D and Zhang Y and Shu G and Chen L and Zhao Z and Chen M and Liu Z and Ji J},
year = {2027},
journal = {Biomaterials},
doi = {10.1016/j.biomaterials.2026.124561},
url = {https://doi.org/10.1016/j.biomaterials.2026.124561}
}RIS
TY - JOUR TI - A novel combination therapy for effective treatment of cancer by designed anti-immunosuppressive nanoregulator and radiofrequency ablation. AU - Fang S AU - Chen J AU - Zheng L AU - Guo X AU - Han M AU - Ding Y AU - Qin P AU - Hou D AU - Zhang Y AU - Shu G AU - Chen L AU - Zhao Z AU - Chen M AU - Liu Z AU - Ji J PY - 2027 JO - Biomaterials DO - 10.1016/j.biomaterials.2026.124561 UR - https://doi.org/10.1016/j.biomaterials.2026.124561 ER -
APA
S, F., J, C., L, Z., X, G., M, H., Y, D., P, Q., D, H., Y, Z., G, S., L, C., Z, Z., M, C., Z, L., & J, J. (2027). A novel combination therapy for effective treatment of cancer by designed anti-immunosuppressive nanoregulator and radiofrequency ablation.. Biomaterials. https://doi.org/10.1016/j.biomaterials.2026.124561
Source records
- pubmed · retrieved 2026-09-26T17:36:12.493Z